Clinical Trial Update: Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration

View source ↗

Summary

This clinical trial update describes implementing a new algorithm for HRR gene mutation testing in metastatic prostate cancer patients using liquid biopsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: European Institute of Oncology | Conditions: Metastatic Prostate Cancer (mPC) | Status: RECRUITING